- Hilton Leeds City
- Thursday 06 & Friday 07 November 2025
- Register here*
This meeting is organised and funded by Teva UK Limited. Views provided by speakers are their own and not necessarily shared by Teva UK Limited. Information at the meeting may discuss drug classes where Teva has a product. Prescribing information will be available at the meeting. The event is open to HCPs from the UK and ROI with an interest in headache and migraine management. *This link will direct you to a promotional webpage.
Adverse events should be reported. Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard for the UK and at http://www.hpra.ie for ROI. Adverse events should also be reported to Teva UK Limited on +44 (0) 207 540 7117 or medinfo@tevauk.com
Teva UK Limited is excited to open registrations for the seventh Head Start meeting taking place on Thursday 06 and Friday 07 November 2025 at the Hilton Leeds City.
Join us to stay engaged in the latest discussions on the management of headache and migraine.
Head Start 2025 will bring together leading neurologists, clinicians, nurses, pharmacists, and healthcare consultants to share best practices, service innovations, and collaborative strategies for improving headache and migraine management across the UK and Ireland.
The agenda has been developed by an expert Steering Committee comprised of Dr Mona Ghadiri-Sani, Professor Peter Goadsby, Dr Krishna Dani, Dr Edward O’Sullivan, Dr Vivek Mehta and Mrs Claire Fisher.
The agenda features talks from renowned specialists, engaging live panel discussions and interactive clinical case studies. Notable highlights include:
- Best practice in migraine treatment: the current landscape
- The pathophysiology of migraine and the link to comorbidities
- Anti-CGRPs – the story so far
- Service improvement skills and workshop on optimising a regional migraine service
Interested in attending? Register here now* This meeting has a limited number of places, your place will not be guaranteed until you receive e-mail confirmation from the meeting Secretariat.
D: MIG-GB-00798 / T: MIG-GB-00799 / M: MIG-GB-00800
Date of Preparation: September 2025
Teva UK Limited, Ridings Point, Whistler Drive, Castleford, WF10 5HX
